NEW YORK (AP) — Thomson Reuters Corp. said today it has acquired a company
called GeneGo that supplies data and analysis for pharmaceutical research and development. Terms were not
disclosed.
GeneGo is aimed at helping pharmaceutical,
biotechnology, and academic research groups understand the genetic mechanisms of
diseases and potential treatments.
Thomson said the business will be integrated into its Healthcare &
Science division.
The healthcare and science division is a part of Thomson Reuters’ larger
Professional segment, which has emerged as the faster growing half of the
company coming out of the recession. The company’s Markets division, which
includes trading terminals and the Reuters news service, was harder hit by the
downturn as financial companies shed jobs and has recovered more slowly.
